Assured Guaranty Ltd.
AGOHIGH VELOCITYFILING INTENSITYAssured Guaranty Ltd. reads as an High Velocity (composite 78/100); Consistent Strategic Buyer deploying $158M across 1 disclosed transactions, up 427% vs the prior cycle · primary market Insurance.
Lens
Disclosed M&A capital (2023–2025)
$158M
vs $30M in 2020–2022
Disclosed transactions
1
1/3 active fiscal years in window
Buyer archetype
Consistent Strategic Buyer
Meaningful spend appears across repeat years.
Composite score
78
High Velocity dominates · Filing Intensity
Behavioral posture, nine reads.
Each index scores the issuer 0–100 against an EDGAR-anchored definition. Scores ≥ threshold elevate the issuer into the index's constituent set; the dominant index drives the masthead label.
Active Acquirer
Companies actively deploying disclosed capital into M&A
- $4B disclosed buyer spend
- Filed within 18d
Buyer Cadence
Buyer-side companies with recent filing activity
- Filed within 18d
- 386 8-Ks
Target Probability
Issuers showing target-side patterns from filings
- 11 activism filings
Spin/Carve
Issuers showing spin-off, carve-out, or sum-of-parts posture
- 11 activism filings
Pressure Watch
Issuers facing activism, governance, or control pressure
- 11 activism filings
- Latest activism 12y ago; heavily discounted
Distress Watch
Issuers showing financial-distress filing patterns
- 11 activism filings
Restatement Risk
Issuers with accounting-integrity flags from filings
- 1 non-reliance 8-K
- 2 NT late filings
- Latest event 15y ago; heavily discounted
Capital Velocity
DominantIssuers with the highest filing-activity intensity
- 386 8-Ks
- Filed within 18d
- 5 form types
Quiet Power
Large issuers with low signal volume and clean disclosure cadence
- Enterprise value $4.8B
- 10-Q 18d ago
- 3 active signals
Capital cadence.
Ten-year disclosed M&A activity. Bars show spend ($MM); ticks show recorded transaction count. Disclosure tier annotated where v6 audited corpus carries an entry.
Disclosed spend $MM Disclosed transactions (right axis)Peak spend year: $443M · Peak count: 1
| FY | Disclosed buys | Disclosed spend | Avg ticket | Audited tier |
|---|---|---|---|---|
| 2025 | 1 | $158M | $158M | N/A |
| 2024 | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
| 2020 | 1 | $30M | $30M | N/A |
Strategy posture.
The buyer's playbook in terms of strategic archetype: what each disclosed move says about how they're deploying capital.
Archetype mix
- Platform25%
- Geographic Expansion25%
- Bolt On25%
- Horizontal Consolidation25%
Strategy keywords
Terms recurring across recent 10-K acquisition disclosures.
- platform
- geographic_expansion
- bolt_on
- horizontal_consolidation
Filing language.
Direct excerpts from acquisition disclosures and strategy sections: the verbs the buyer chose, in the filings they signed.
“The Assured Life Re Acquisition represents the Company's first platform dedicated solely to the life and annuity reinsurance business, further diversifying the risk profile and revenue opportunities of the Company.”
“The Company focuses investments in post-acute and long-term care, behavioral and mental health, physician practice management, regional health systems, and payer and provider services (non-clinical).”
“Healthcare Investing. AssuredIM established its private healthcare strategy in 2013. Through its healthcare opportunity funds, the Company offers to the healthcare services industry flexible capital solutions supporting mergers and acquisitions, acceleration of organic growth, consolidation, repositioning, shareholder liquidity, and restructuring opportunities. The Company focuses investments in post-acute and long-term care, behavioral and mental health, physician practice management, regional health systems, and payer and provider services (non-clinical).”
“AssuredIM established its private healthcare strategy in 2013. Through its healthcare opportunity funds, the Company offers to the healthcare services industry flexible capital solutions supporting mergers and acquisitions, acceleration of organic growth, consolidation, repositioning, shareholder liquidity, and restructuring opportunities.”
“the Company now operates in two distinct segments, Insurance and Asset Management”
Market context.
Where this issuer sits inside its SE-Cluster rollup wedge, with disclosed-spend rank plus trading comparables against the public peer set.
Primary market
Insurance
- Market spend (2023–2025)
- $50.4B
- Market spend (2020–2022)
- $62.2B
- Recent vs prior
- −19%
- Issuer rank in market
- N/A
- Share of market capital
- 0.0%
Valuation positioning
AGO trades at a -2.7-turn discount to the Insurance peer median of 11.6×.
- EV / Revenue
- 5.0×
- Net debt / EBITDA
- 2.6×
- Peer median EV / EBITDA
- 11.6×
Trading comparables
FMP market data · 2026-05-10
| Company | EV / EBITDA | EV / Rev | Net debt / EBITDA | Revenue | M&A 2023–2025 |
|---|---|---|---|---|---|
| 14.9× | 3.6× | 2.8× | $27.5B | $10.2B | |
| 12.1× | 4.1× | 3.1× | $6.4B | $9.4B | |
| 11.2× | 2.3× | -0.1× | $61.1B | $1.3B | |
Assured Guaranty Ltd.AGO | 8.9× | 5.0× | 2.6× | $951M | $158M |
| 8.2× | 0.6× | -3.8× | $76.9B | $738M |
Trading multiples from FMP market data; disclosed M&A spend from the SE-Cluster EDGAR 10-K corpus. Peer set = top disclosed buyers in Insurance. Bars scaled to the highest EV/EBITDA in the set.
Target landscape.
Public-issuer targets that fit this buyer's archetype and target categories from filing-derived signal. Scores reflect cross-signal fit; reasons cite the EDGAR-anchored facts that drove the match.
No qualifying public-issuer targets surfaced from the current signal mix.
Stated target categories
No target categories enumerated in the audited corpus for this issuer.
Filing activity & signal stream.
Filing cadence and event-driven signals visible on EDGAR. The signal stream below is curated from restatement / spin-carve / activism categories, providing context for any near-term call.
Filing cadence
- 10-K (annual)242026-02-27
- 10-Q (quarterly)692026-05-08
- 8-K (event)3862026-05-08
- Proxy / DEF 14A522026-04-13
- Activism (13D / DFAN / PREC)112014-07-01
Signals on file
- critical
Non-reliance disclosure
2011-10-181 Item 4.02 filing on file; financial-statement non-reliance.
- watch
Late-filing notice
2011-11-102 NT 10-K/10-Q filings on file.
- elevated
Activism on file
2014-07-0111 activist filings on file (13D, DFAN14A, PREC14A series).
- info
Signal
Serial acquisition history
- info
Signal
10-K strategy themes
- info
Signal
Restatement risk
Audited corpus.
No audited record on file for this CIK in the current v6 corpus.
This issuer has not been extracted into the v6 audited acquirer corpus yet. The brief above pulls from ranking-level aggregates and issuer-index signal only.